Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
COCP similar filings
- 15 Mar 23 Regulation FD Disclosure
- 9 Jan 23 Regulation FD Disclosure
- 26 Oct 22 Enrollment Completed in Phase 1 Influenza A Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344
- 3 Oct 22 Amendments to Articles of Incorporation or Bylaws
- 12 Sep 22 Regulation FD Disclosure
- 15 Aug 22 Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
- 29 Jul 22 Departure of Directors or Certain Officers
Filing view
External links